Gram-positive resistance: challenge for the development of new antibiotics

F Baquero1

  • 1Departamento de Microbiología, Ramón y Cajal Hospital, Madrid, Spain.

Insights

Multidrug-resistant Gram-positive infections are rising, posing treatment challenges. A new streptogramin, quinupristin/dalfopristin, shows promise for combating these difficult-to-treat pathogens.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • The incidence of infections caused by multidrug-resistant Gram-positive organisms is increasing.
  • These infections are difficult to treat due to widespread resistance to existing antibacterial therapies.
  • Key problematic pathogens include resistant strains of Streptococcus pneumoniae, enterococci, and Staphylococcus aureus.

Purpose of the Study:

  • To highlight the urgent need for novel antibacterial agents effective against multidrug-resistant Gram-positive pathogens.
  • To introduce quinupristin/dalfopristin as a potential therapeutic option.

Main Methods:

  • Review of current literature on multidrug-resistant Gram-positive infections.
  • Identification of key resistant pathogens and their resistance profiles.
  • Introduction of a novel semisynthetic injectable streptogramin.

Main Results:

  • Identified numerous multidrug-resistant Gram-positive pathogens, including Streptococcus pneumoniae, enterococci, Staphylococcus aureus, and others.
  • Documented resistance to various antibiotic classes such as beta-lactams, macrolides, aminoglycosides, and glycopeptides.
  • Highlighted quinupristin/dalfopristin as a promising agent against these resistant strains.

Conclusions:

  • There is a critical need for new antibacterial agents to address the growing threat of multidrug-resistant Gram-positive infections.
  • Quinupristin/dalfopristin represents a novel therapeutic prospect for treating infections caused by a range of challenging multidrug-resistant Gram-positive organisms.

Related Concept Videos

Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...